Heavy Smart Phone UsersNCT06112496
Effect of Smartphone Addiction on Myoelectrical Activity of Sternocleidomastoid Muscle in Adult
An observational study of Heavy Smart Phone Users, run by Cairo University at 1 site in Egypt.
Trial summary
This study will be conducted to identify the effect of smartphone addiction myoelectrical activity on sternocleidomastoid in adults by measuring The amplitude of EMG signals of the sternocleidomastoid muscle in adults and Root mean square of EMG signals of the sternocleidomastoid muscle in adults Read more about this study
- Who is it for?
- Ages 18 to 30 years
- Conditions the study is for
- Heavy Smart Phone Users
- What is being tested?
- EMG
- Type of treatment
- Medical device
- How many people
- 44 participants
- Where
- 1 siteEgypt
- Study dates
- 23 Nov 2023to 21 Dec 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 30 years
- All sexes
- No healthy volunteers
- Adult
Study population: smart phone users
Who may be able to join
- Subject's age range from 18-30 years old
- All participants use the same smartphone with a touch screen of 6,7 inches.
Who cannot join
- Neck pain ( spondylosis, spondylolysis)
- Systemic diseases.
- Spinal deviation
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effect of Smartphone Addiction on the Myoelectrical Activity of the Sternocleidomastoid Muscle in Adult
This study will be conducted to identify the effect of smartphone addiction myoelectrical activity on sternocleidomastoid in adults by measuring The amplitude of EMG signals of the sternocleidomastoid muscle in adults and Root mean square of EMG signals of the sternocleidomastoid muscle in adults
- Conditions
- Heavy Smart Phone Users
- Being tested
- EMG
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
EMGDevice
Neuro-EMG-Micro, Neurosoft, Ivanovo, Russia, will be used for the assessment of muscle activity for muscles.
| Study group | Role | What they receive |
|---|---|---|
| smart phone addict | Not described Receives: Device: EMG | |
| smart phone non addict | Not described Receives: Device: EMG |
What is being measured
The primary outcome is the main question the study is designed to answer.
Changes in surface electromyographic (EMG) amplitude of sternocleidomastoid muscle
change in amplitude measured by EMG device
Measured: day 1
change in RMS
change in root mean square measured by EMG device
Measured: day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Nov 2023
- Study start23 Nov 2023
- Primary completion16 Dec 2023
- Study completion21 Dec 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Heavy Smart Phone UsersStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 44 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Huda Adel Mohammed Hassan, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06112496
- Sponsor's protocol ID
- P.T.REC/012/004614
- Status last verified
- Feb 2024
- First submitted
- 19 Oct 2023
- Last updated
- 7 Feb 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Smartphone Addiction on the Myoelectrical Activity of the Sternocleidomastoid Muscle in Adult
- ClinicalTrials.gov ID
- NCT06112496
- Acronym / sponsor ID
- P.T.REC/012/004614
- Conditions
- Heavy Smart Phone Users
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 44 participants (actual)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 23 Nov 2023 (actual)
- Primary completion
- 16 Dec 2023 (actual)
- Study completion
- 21 Dec 2023 (actual)
- First posted
- 1 Nov 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will be conducted to identify the effect of smartphone addiction myoelectrical activity on sternocleidomastoid in adults by measuring The amplitude of EMG signals of the sternocleidomastoid muscle in adults and Root mean square of EMG signals of the sternocleidomastoid muscle in adults
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| smart phone addict | – | Device: EMG |
| smart phone non addict | – | Device: EMG |
Who may qualify
- Ages
- 18 to 30 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- smart phone users
Key inclusion criteria (2 listed)
- Subject's age range from 18-30 years old
- All participants use the same smartphone with a touch screen of 6,7 inches.
Key exclusion criteria (3 listed)
- Neck pain ( spondylosis, spondylolysis)
- Systemic diseases.
- Spinal deviation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| EMGNeuro-EMG-Micro, Neurosoft, Ivanovo, Russia, will be used for the assessment of muscle activity for muscles. | Device | smart phone addict, smart phone non addict |
Primary outcome
Changes in surface electromyographic (EMG) amplitude of sternocleidomastoid muscle
Time frame: day 1
change in amplitude measured by EMG device
change in RMS
Time frame: day 1
change in root mean square measured by EMG device
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Feb 2024.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Heavy Smart Phone Users, run by Cairo University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Changes in surface electromyographic (EMG) amplitude of sternocleidomastoid muscle (time frame: day 1). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Feb 2024.